Jobs / United States / Sanofi US Services INC
Real World Evidence Strategy Lead
Sanofi US Services INC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Sanofi US Services INC
The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Sanofi US Services INC →
About the role
Job title : Real World Evidence Strategy Lead • Location: Morristown, NJ, Cambridge, MA About the Job As the Real-World Evidence (RWE) Strategy Lead, you will establish and execute RWE strategies across global Therapeutic Areas, translating medical needs into evidence that drives regulatory, access and medical decisions. Working in close partnership across Medical, Market Access, Health Economics Value and Access, and other cross-functional Brand teams, you lead through influence to deliver innovative, scientifically rigorous real-world studies that generate critical insights and measurable business impact The Real-World Evidence (RWE) team in OneMedical Pharmacovigilance and Patient Safety (PSPV) serves as an end-to-end strategy and execution partner to solve business problems using real-world data. We partner with cross functional partners to lead end-to-end planning and execution of RWE strategies. Operating across both our General Medicines (GenMed) and Specialty Care Global Business Units, our RWE team sits at the intersection of data science, medical strategy, and scientific leadership, translating complex real-world data into meaningful insights that drive patient outcomes. We are on an ambitious journey to build a best-in-class RWE capability, harnessing innovative methodologies, cutting-edge real-world data sources, and AI-powered analytics to stay at the forefront of evidence generation. Join the engine of Sanofi’s mission — where deep immunoscience meets bold, AI-powered research. In R&D, you’ll drive breakthroughs that could turn the impossible into possible for millions. About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives. Main responsibilities: The RWE Strategy Lead is a strategic position responsible for establishing the RWE strategy for the relevant global franchise with dedicated assets / brands for agreed indications and other lifecycle strategies in development. He/she is accountable for the end-to-end execution of real- world studies. This role works in close partnership with Global Medical Leads, Global Market Access and HEVA Leads and other cross-functional partner across the Global Brand Teams to co-create and ensure strategic alignment of the evidence strategy while orchestrates internal and external expertise and resources to deliver flawless execution of studies. This is a critical role to translate and realize the brand and medical strategy into a fit-for-purpose evidence strategy that delivers scientific value and business impact. • Build the asset / brand RWE strategy in alignment with the global disease area strategy; translate medical needs into evidence requirements that is fit for intended purposes for clinical, or regulatory decision-making. • Accountable for supporting GenMed medical gaps within the Global Integrated Evidence Generation Plans (IEGP). • Partner with Global Medical Lead(s) to ensure robust integrated evidence generation plans (IEGP) that are built with timely and relevant contributions from internal and external global and local experts; and that IEGPs are communicated and documented consistently across strategic plans, brand plans and medical plans. • Develop data strategy that enables the realization of the evidence strategy; determine data availability, access and suitability from internal and external sources, in collaboration with the Real-World Data Strategic Partnership Lead as needed. • Build an understanding of TA lead and follow